Test Code LAB20910 Amino Acids, Quantitative, Random, Urine
Reporting Name
Amino Acids, QN, Random, UUseful For
Evaluating patients with possible inborn errors of metabolism using random urine specimens
May aid in evaluation of endocrine disorders, liver diseases, muscle diseases, neoplastic diseases, neurological disorders, nutritional disturbances, kidney failure, and burns
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
UrineAdditional Testing Requirements
Not all patients with homocystinuria will be detected by this assay. If homocystinuria is a concern, order CMMPP / Cobalamin, Methionine, and Methylmalonic Acid Pathways, Plasma or HCYSP / Homocysteine, Total, Plasma or HCYSS / Homocysteine, Total, Serum in tandem with this test.
Necessary Information
1. Patient's age is required.
2. Include family history, clinical condition (asymptomatic or acute episode), diet, and drug therapy information.
3. If prolidase deficiency is a concern, indicate on the amino acid order "Pretreat with acid hydrolysis prior to analysis". The acid hydrolysis will break up in vitro proline and hydroxyproline containing dipeptides, which are cleaved in vivo by prolidase.
Specimen Required
Supplies: Urine Tubes, 10 mL (T068)
Specimen Volume: 2 mL
Collection Instructions: Collect a random urine specimen.
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Frozen (preferred) | 70 days | |
Refrigerated | 14 days |
Reference Values
Amino Acid |
Age groups |
|||||
< 2 months |
2-35 months |
3-6 years |
7-17 years |
≥18 years |
||
Taurine |
Tau |
<9026 |
<5604 |
<3680 |
<3954 |
<2134 |
Asparagine |
Asn |
<687 |
<1159 |
<238 |
<322 |
<204 |
Serine |
Ser |
<3202 |
<2741 |
<1386 |
<1116 |
<658 |
Hydroxyproline |
Hyp |
<2254 |
<1775 |
<89 |
<42 |
<48 |
Glycine |
Gly |
<13336 |
<9872 |
<4997 |
<4467 |
<4068 |
Glutamine |
Gln |
<2931 |
<3681 |
<1124 |
<1038 |
<764 |
Aspartic Acid |
Asp |
<290 |
<72 |
<46 |
<13 |
<12 |
Ethanolamine |
EtN |
<1589 |
<1765 |
<776 |
<536 |
<500 |
Histidine |
His |
<3806 |
<4578 |
<2596 |
<2294 |
<1508 |
Threonine |
Thr |
<1930 |
<1769 |
<496 |
<575 |
<384 |
Citrulline |
Cit |
<61 |
<67 |
<23 |
<17 |
<34 |
Sarcosine |
Sar |
<177 |
<52 |
<6 |
<10 |
<6 |
Beta-Alanine |
bAla |
<174 |
<79 |
<99 |
<139 |
<58 |
Alanine |
Ala |
<2856 |
<2360 |
<961 |
<794 |
<472 |
Glutamic Acid |
Glu |
<281 |
<210 |
<127 |
<63 |
<62 |
1-Methylhistidine |
1MHis |
<493 |
<470 |
<517 |
<453 |
<265 |
3-Methylhistidine |
3MHis |
<196 |
<662 |
<3346 |
<2027 |
<1920 |
Argininosuccinic Acid |
Asa |
<96 |
<103 |
<65 |
<57 |
<37 |
Homocitrulline |
Hcit |
<164 |
<169 |
<110 |
<107 |
<87 |
Arginine |
Arg |
<250 |
<147 |
<81 |
<42 |
<65 |
Alpha-aminoadipic Acid |
Aad |
<264 |
<397 |
<349 |
<138 |
<73 |
Gamma Amino-n-butyric Acid |
GABA |
<8 |
<14 |
<4 |
<3 |
<4 |
Beta-aminoisobutyric Acid |
bAib |
<2214 |
<2488 |
<840 |
<251 |
<265 |
Alpha-amino-n-butyric Acid |
Abu |
<58 |
<44 |
<37 |
<29 |
<19 |
Hydroxylysine |
Hyl |
<101 |
<87 |
<44 |
<22 |
<16 |
Proline |
Pro |
<1776 |
<1028 |
<29 |
<42 |
<98 |
Ornithine |
Orn |
<344 |
<238 |
<228 |
<291 |
<193 |
Cystathionine |
Cth |
<118 |
<53 |
<23 |
<24 |
<33 |
Cystine |
Cys |
<486 |
<285 |
<111 |
<84 |
<142 |
Lysine |
Lys |
<2217 |
<1321 |
<814 |
<463 |
<295 |
Methionine |
Met |
<76 |
<45 |
<24 |
<22 |
<15 |
Valine |
Val |
<308 |
<258 |
<119 |
<91 |
<73 |
Tyrosine |
Tyr |
<453 |
<603 |
<289 |
<371 |
<155 |
Isoleucine |
Ile |
<99 |
<131 |
<52 |
<29 |
<26 |
Leucine |
Leu |
<286 |
<215 |
<87 |
<70 |
<64 |
Phenylalanine |
Phe |
<342 |
<306 |
<178 |
<123 |
<98 |
Tryptophan |
Trp |
<241 |
<329 |
<222 |
<218 |
<140 |
Allo-isoleucine |
AlloIle |
<3 |
<6 |
<1 |
<2 |
<4 |
All results reported as nmol/mg creatinine.
Day(s) Performed
Monday through Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82139
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
AAPD | Amino Acids, QN, Random, U | 35087-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
3481 | Interpretation (AAPD) | 49248-8 |
3452 | Taurine | 28595-7 |
3456 | Asparagine | 28603-9 |
3455 | Serine | 30058-2 |
34477 | Hydroxyproline | 28601-3 |
3460 | Glycine | 30066-5 |
3457 | Glutamine | 30056-6 |
34478 | Aspartic Acid | 30061-6 |
34479 | Ethanolamine | 28605-4 |
3477 | Histidine | 30047-5 |
3454 | Threonine | 30057-4 |
3459 | Citrulline | 30161-4 |
34480 | Sarcosine | 28610-4 |
3472 | Beta-alanine | 28588-2 |
3461 | Alanine | 30068-1 |
3458 | Glutamic Acid | 30059-0 |
3476 | 1-Methylhistidine | 28606-2 |
3478 | 3-Methylhistidine | 28594-0 |
34481 | Argininosuccinic Acid | 32229-7 |
34483 | Homocitrulline | 32248-7 |
3480 | Arginine | 30062-4 |
3462 | Alpha-aminoadipic Acid | 28598-1 |
34484 | Gamma-amino-n-butyric Acid | 28593-2 |
3473 | Beta-aminoisobutyric Acid | 28602-1 |
3463 | Alpha-amino-n-butyric Acid | 28590-8 |
34485 | Hydroxylysine | 30050-9 |
3483 | Proline | 30067-3 |
3474 | Ornithine | 30049-1 |
3466 | Cystathionine | 28599-9 |
3465 | Cystine | 30065-7 |
3475 | Lysine | 30048-3 |
3467 | Methionine | 30063-2 |
3464 | Valine | 30064-0 |
3470 | Tyrosine | 30054-1 |
3468 | Isoleucine | 30052-5 |
3469 | Leucine | 30053-3 |
3471 | Phenylalanine | 30055-8 |
34486 | Tryptophan | 28608-8 |
34487 | Allo-isoleucine | 73908-6 |
113130 | Reviewed By | 18771-6 |
Clinical Information
Amino acids are the basic structural units that comprise proteins and are found throughout the body. Many inborn errors of amino acid metabolism that affect amino acid transport or metabolism have been identified, such as phenylketonuria and tyrosinemia. Amino acid disorders can manifest at any age, but most become evident in infancy or early childhood. These disorders result in the accumulation or the deficiency of 1 or more amino acids in biological fluids, which leads to the clinical signs and symptoms of the specific amino acid disorder.
The clinical presentation is dependent upon the specific amino acid disorder. In general, affected patients may experience failure to thrive, neurologic symptoms, digestive problems, dermatologic findings, and physical and cognitive delays. If not diagnosed and treated promptly, amino acid disorders can result in intellectual disabilities and, possibly, death.
In addition, amino acid analysis may have clinical importance in the evaluation of several acquired conditions including endocrine disorders, liver diseases, muscle diseases, neoplastic diseases, neurological disorders, nutritional disturbances, kidney failure, and burns. General elevations in urine amino acid levels, called aminoaciduria, can be seen in disorders with amino acid transport defects, such as lysinuric protein intolerance and Hartnup disease, as well as in conditions with renal tubular dysfunction including Lowe syndrome and Dent disease.
Interpretation
When no significant abnormalities are detected, a simple descriptive interpretation is provided. When abnormal results are detected, a detailed interpretation is given, including an overview of the results and of their significance, a correlation to available clinical information, elements of differential diagnosis, recommendations for additional biochemical testing and in vitro confirmatory studies (enzyme assay, molecular analysis), name and phone number of key contacts who may provide these studies, and a phone number to reach one of the laboratory directors in case the referring physician has additional questions.
Method Description
Quantitative analysis of amino acids is performed by liquid chromatography-tandem mass spectrometry. Patient samples are combined with isotopically labeled internal standard. Following protein precipitation, the supernatant is subjected to hydrophilic-interaction liquid chromatography for the separation of isomers with MS/MS detection of the underivatized amino acids.(Unpublished Mayo method)
Report Available
3 to 5 daysReject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Testing Algorithm
Testing includes quantitation of the following amino acids: taurine, threonine, serine, asparagine, hydroxyproline, glutamic acid, glutamine, aspartic acid, ethanolamine, sarcosine, proline, glycine, alanine, citrulline, alpha-aminoadipic acid, alpha-amino-n-butyric acid, valine, cystine, cystathionine, methionine, isoleucine, leucine, tyrosine, phenylalanine, beta-alanine, beta-aminoisobutyric acid, ornithine, lysine, 1-methylhistidine, histidine, 3-methylhistidine, argininosuccinic acid, allo-isoleucine, homocitrulline, gamma-amino-n-butyric acid, hydroxylysine, tryptophan, and arginine.
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Portions of this test are covered by patents held by Quest Diagnostics
Forms
If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.